Reservoir-Type LNG Delivery System
- User: Female
- Hormonal: Hormonal
-
Delivery type:
- Subdermal
-
Intended Duration:
- Short-Acting
- Development Stage: Pre-Clinical
- Developer(s)/researcher(s): Tehran University
Details
- API: Levonorgestrel
- Target: Progesterone Receptor, Androgen Receptor
-
Mechanism of Action:
- Ovulation Inhibition
- Cervical Mucus Changes
- Endometrial Changes
- Inactive Materials: PLA
- Regimen: 1 Insertion/TBD Months
- MPT: Not Potential MPT
Product Status
No additional publications. Unable to source information about research team.
History
Limited development information. Appears to be inactive.